Nicole R. Grieselhuber

Nicole R. Grieselhuber's research focuses on blood cancers such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML), and on complications following stem cell transplantation, such as chronic graft-versus-host disease (cGVHD), a condition where transplanted immune cells attack the recipient's body. Much of the work involves testing small-molecule drugs, including inhibitors of specific enzymes (such as BET proteins, PKCβ, and histone deacetylases) that block cancer cell growth or immune-driven tissue damage, often in laboratory and animal (mouse) models. This work is aimed at identifying new drug candidates and understanding resistance to existing therapies like BTK inhibitors.

Publication output has grown substantially over the past decade, rising from just a few papers per year around 2017 to over 20 per year by 2023 and 2026, though with some year-to-year fluctuation.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026